Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Qiao Li
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC)
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
30
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
The Different Sequences of Cdk4/6 Inhibitor and Mtor Inhibitor in Hr+/Her2- Advanced Breast Cancer: A Multicenter Real-World Study
Number of pages: 19
Posted: 22 Jul 2024
Yuqian Liao
,
Yujing Tan
,
Yipeng Li
,
Fei Ma
,
Jiayu Wang
,
Pin Zhang
,
Qing Li
, Qiao Li,
Yang Luo
,
Bo Lan
,
Shanshan chen
,
Binghe Xu
,
Hanfang Jiang
,
Weihong Zhao
and
Ying Fan
Jiangxi Medical College, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC),
affiliation not provided to SSRN
, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Tianjin Medical University - National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chinese Academy of Medical Sciences - Department of Medical Oncology, Beijing University, Government of the People's Republic of China - Chinese PLA General Hospital and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC)
Downloads
30
(1,318,317)
View PDF
Download
Abstract:
therapeutic sequence, CDK4/6 inhibitor, everolimus, survival outcome
Feedback